Pierrick Bourgeat
Pierrick Bourgeat
CSIRO eHealth Research Centre - Biomedical Informatics Group – Image analysis Team , Australia
Verified email at csiro.au
Title
Cited by
Cited by
Year
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
The Lancet Neurology 12 (4), 357-367, 2013
1347*2013
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ...
Neurobiology of aging 31 (8), 1275-1283, 2010
8752010
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
7302011
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
3492010
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ...
Neurology 74 (2), 121-127, 2010
2272010
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ...
Brain 135 (7), 2126-2139, 2012
1972012
Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
S Frost, Y Kanagasingam, H Sohrabi, J Vignarajan, P Bourgeat, ...
Translational psychiatry 3 (2), e233-e233, 2013
1712013
Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ...
Annals of neurology 74 (6), 905-913, 2013
1662013
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease
V Doré, VL Villemagne, P Bourgeat, J Fripp, O Acosta, G Chetélat, L Zhou, ...
JAMA neurology 70 (7), 903-911, 2013
1502013
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a …
SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ...
The Lancet Neurology 15 (10), 1044-1053, 2016
1272016
Larger temporal volume in elderly with high versus low beta-amyloid deposition
G Chételat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ...
Brain 133 (11), 3349-3358, 2010
123*2010
Larger temporal volume in asymptomatic elderly with high versus low beta-amyloid deposition
G Chetelat, V Villemagne, K Pike, JC Baron, P Bourgeat, G Jones, K Ellis, ...
Alzheimer's & Dementia: The Journal of the Alzheimer's Association 6 (4), S2-S3, 2010
120*2010
Automated voxel-based 3D cortical thickness measurement in a combined Lagrangian–Eulerian PDE approach using partial volume maps
O Acosta, P Bourgeat, MA Zuluaga, J Fripp, O Salvado, S Ourselin, ...
Medical image analysis 13 (5), 730-743, 2009
1012009
Detecting global and local hippocampal shape changes in Alzheimer's disease using statistical shape models
K Shen, J Fripp, F Mériaudeau, G Chételat, O Salvado, P Bourgeat, ...
Neuroimage 59 (3), 2155-2166, 2012
992012
Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease
G Chetelat, VL Villemagne, KE Pike, KA Ellis, P Bourgeat, G Jones, ...
Brain 134 (3), 798-807, 2011
992011
Lesion segmentation from multimodal MRI using random forest following ischemic stroke
J Mitra, P Bourgeat, J Fripp, S Ghose, S Rose, O Salvado, A Connelly, ...
NeuroImage 98, 324-335, 2014
922014
Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline
S Ayton, A Fazlollahi, P Bourgeat, P Raniga, A Ng, YY Lim, I Diouf, ...
Brain 140 (8), 2112-2119, 2017
912017
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease
RF Buckley, P Maruff, D Ames, P Bourgeat, RN Martins, CL Masters, ...
Alzheimer's & Dementia 12 (7), 796-804, 2016
892016
Aβ-amyloid and tau imaging in dementia
VL Villemagne, V Doré, P Bourgeat, SC Burnham, S Laws, O Salvado, ...
Seminars in nuclear medicine 47 (1), 75-88, 2017
872017
BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease
YY Lim, VL Villemagne, SM Laws, D Ames, RH Pietrzak, KA Ellis, ...
Neurobiology of aging 34 (11), 2457-2464, 2013
872013
The system can't perform the operation now. Try again later.
Articles 1–20